POST-ACUTE COVID-19
Clinical trials for POST-ACUTE COVID-19 explained in plain language.
Never miss a new study
Get alerted when new POST-ACUTE COVID-19 trials appear
Sign up with your email to follow new studies for POST-ACUTE COVID-19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could an antiviral pill ease long COVID? new trial investigates
Disease control OngoingThis study tests whether the antiviral drug ensitrelvir can help people with long COVID by targeting leftover virus in the body. About 40 adults with long COVID symptoms will receive either the drug or a placebo for 10 days. Researchers will measure changes in physical health and…
Matched conditions: POST-ACUTE COVID-19
Phase: PHASE2 • Sponsor: Timothy Henrich • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
Could an antibody ease long COVID? new study begins
Symptom relief OngoingThis study tests whether a lab-made antibody called AER002 can safely help adults with Long COVID feel better. Long COVID may be caused by leftover virus in the body, and this antibody aims to target that virus. 36 participants will receive either the antibody or a placebo, and r…
Matched conditions: POST-ACUTE COVID-19
Phase: PHASE2 • Sponsor: Michael Peluso, MD • Aim: Symptom relief
Last updated May 07, 2026 18:41 UTC